Can chronic immune activation cause persistent fatigue and widespread pain?

The relationship between chronic immune activation and persistent symptoms like fatigue and widespread pain is well-supported by clinical and mechanistic research. This connection is primarily mediated by the interaction between peripheral inflammatory cytokines and the central nervous system (CNS).

Clinical and biological evidence

Research consistently demonstrates that patients with conditions like fibromyalgia (FM) and chronic fatigue syndrome (CFS) exhibit elevated levels of pro-inflammatory cytokines.

• Cytokine Profiles: Meta-analyses have identified significant elevations in interleukin-6 (IL-6) (SMD = 0.61) and tumor necrosis factor-alpha (TNF-α) in individuals with FM compared to healthy controls.
• Systemic to CNS Communication: These cytokines are capable of crossing the blood-brain barrier or signaling via the vagus nerve to trigger neuroinflammation, which is a fundamental driver of centralized pain and fatigue.
• HPA Axis Impact: Chronic cytokine elevation often leads to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, further exacerbating neuroendocrine-immune imbalances that manifest as exhaustion.

Mechanistic pathways

The transition from acute immune response to chronic symptom expression involves two key pathways:

• Sickness-Behavior Signaling: Pro-inflammatory mediators like IL-1β, TNF-α, and IL-6 act on the ventromedial hypothalamus to induce sickness behavior—an adaptive response characterized by reduced activity and muscle weakness. When these signals become sustained, they manifest as chronic fatigue.
• Neuroimmune Sensitization: Chronic signaling leads to microglial hyperactivity. These activated microglia release brain-derived neurotrophic factor (BDNF) and other mediators that lower the threshold for nociception (pain perception) and amplify pain signals. This process, known as central sensitization, results in the widespread pain typical of many chronic inflammatory conditions.

Bottom line

Chronic immune activation drives fatigue and pain through the persistent engagement of the brain's sickness-behavior pathways and the sensitization of neuroimmune cells. This suggests that targeting systemic inflammation and microglial activation may be critical for managing centralized symptoms in patients with persistent fatigue and pain syndromes.